Clinical Trials Update: May 4, 2004

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Ovarian Cancer HIV

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

A research study to evaluate the efficacy and safety of an experimental drug in patients with Chronic Inflammatory Demyelinating Polyneurpathy (CIDP). Volunteers 18 or older who are newly or previously diagnosed with CIDP and have not taken steroids > 10mg/day in the last three months may be eligible. Research site located in Manhasset, NY.

More information

Please see http://www.centerwatch.com/patient/studies/cat288.html.

-----

Ovarian Cancer

A research study of an investigational medication for the treatment of ovarian cancer. Female volunteers 18 or older who have been diagnosed with epithelial cancer of the ovary, fallopian tube or primary peritoneal cancer that has progression after platinum-based chemotherapy may be eligible. Research sites located throughout the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat186.html.

-----

HIV

A research study of an investigational medication for patients with painful HIV-associated neuropathy. Volunteers who have had HIV-associated neuropathy for at least two months, with moderate to severe pain in both feet, and do not have significant pain in the feet due to other causes (for example, arthritis) may be eligible. Research site located in Vero Beach, Fla.

More information

Please see http://www.centerwatch.com/patient/studies/cat417.html.

-----

Copyright 2004 CenterWatch. All rights reserved.

Related Stories

No stories found.
logo
www.healthday.com